Similarly, cancer-derived fumarate suppresses CD8+ T cell anti-tumor function, yet its therapeutic depletion enhances CAR-T cell anti-tumor efficacy (40); in parallel, fumarate inhibits B cell activation, proliferation, and inflammatory responses (41). This evidence concerns the gene CD8A and neoplasm.